Figure 3 | Scientific Reports

Figure 3

From: Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy

Figure 3

Forest plots of clinical outcomes in advanced lung cancer patients treated with platinum-based chemotherapy by the XRCC1 Arg399Gln polymorphism.

(A) Odds ratios (ORs) (and its 95% confidence interval (CI)) of objective response rate (ORR) stratified by ethnicity for GlnGln+GlnArg vs. ArgArg. (B) Hazard ratios (HRs) (and its 95% CI) of overall survival (OS) stratified by ethnicity for GlnGln vs. ArgArg. (C) HRs (and its 95% CI) of median progression-free survival (PFS) stratified by ethnicity for GlnGln vs. ArgArg.

Back to article page